Claim it free in under 5 minutes — verified by GSTIN, DigiLocker, or WhatsApp OTP. You control what buyers see, respond to inquiries, and post on RFQs.
AICure built H.Code, the world's first AI-powered adherence verification platform trusted by pharma, CROs, and providers to verify medication and clinical behavior adherence across the healthcare lifecycle. H.Code, by AiCure, uses AI-powered computer vision, synchronous chat, and predictive analytics to observe and assist trial participants through their smartphone—revolutionizing access and participation, improving statistical power, and deepening our understanding of the relationship between patient behavior and trial outcomes. Our research shows that medication adherence captured through AiCure’s AI-powered platform, H.Code, can serve as a marker for participant retention and that early adherence is predictive of future early termination risk. This technology, coupled with AiCure’s central monitoring framework, Clinical Site Services (CSS), reduced early termination rates for adherent participants to just 7.8% across 28 phase I-IV clinical trials with over 4,000 patients representative of 43 countries. H.Code is designed to be a bridge between your patients and your clinical team. Our unique approach combines cutting-edge patient engagement AI technology with extensive site expertise in one solution, making clinical trials more convenient and accessible for participants and more manageable and effective for clinical sites and study teams.
Anchored to live government registries — MCA, GSTN, DGFT, EPFO. No pay-to-play badges. Refreshed weekly.
Limited government data available — 5 criteria met
AICURE INDIA PRIVATE LIMITED is anchored to the official records above. Anything self-declared by the company is labelled separately on this page. Check another company free →
Other verified manufacturers in the same network — discovered via MCA21 cross-references.